伊朗心肌梗塞:流行病学,管理和预后
Mohammad Reza Beyranvand1, Hootan Manhoobi2, Saeid Shahraz3
1Department of Cardiology, Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
The journal of Tehran Heart Center
|August 28, 2023
概括
急性心肌梗塞 (AMI) 是一个主要的全球杀手. 本综述详细介绍了伊朗的AMI特征,强调需要进行国家监测,以改善公共卫生结果.
科学领域:
- 心脏病学 心脏病学
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 急性心肌梗塞 (AMI) 代表了全球健康的重大负担.
- 心血管疾病是全球死亡的主要原因.
- 了解AMI的区域特征对于有针对性的干预至关重要.
研究的目的:
- 阐明伊朗急性心肌梗塞 (AMI) 的流行病学特征.
- 综合有关伊朗人口中AMI发病率,患者人口统计和结局的现有数据.
主要方法:
- 使用PubMed,谷歌和谷歌学者进行了全面的文献搜索.
- 关键词包括"心肌梗塞"",STEMI"和"MI+伊朗"在英语和波斯语.
- 数据提取的重点是发病率,患者年龄,住院死亡率和并发症率.
主要成果:
- 心肌梗塞 (MI) 的年龄标准化发病率为每10万人口中的73.3.
- 患者的平均年龄为61.20±13.40岁,IMIR登记处的住院死亡率为12.1%.
- 报告的并发症包括腹腔动心 (5.8%) 和腹腔 (2.5%),在IPACE2研究中,1年死亡率为4.3%.
结论:
- 在伊朗,关于急性心肌梗塞 (AMI) 的综合性国家研究很少.
- 建立持续的联邦冠状动脉事件监测计划至关重要.
- 这样的计划将大大有助于提高伊朗人口的整体健康.
相关概念视频
Myocarditis III: Medical Management
7
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
7
Myocarditis IV: Nursing Management
13
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
13
Myocarditis I: Introduction
9
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
9
Angina IV: Management
11
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
11
Pericarditis III: Medical Management
13
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
13
Acute Coronary Syndrome IV: Interprofessional Care
12
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
12


